.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Daiichi Sankyo
Fuji
Covington
McKesson
Cipla
Julphar
Medtronic
McKinsey

Generated: June 27, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: pemetrexed disodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly
ALIMTA
pemetrexed disodium
INJECTABLE;IV (INFUSION)021462NDAEli Lilly and Company0002-7623-011 VIAL in 1 CARTON (0002-7623-01) > 20 mL in 1 VIAL
Lilly
ALIMTA
pemetrexed disodium
INJECTABLE;IV (INFUSION)021462NDAEli Lilly and Company0002-7640-011 VIAL in 1 CARTON (0002-7640-01) > 4 mL in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Boehringer Ingelheim
Accenture
Farmers Insurance
Daiichi Sankyo
Johnson and Johnson
Merck
Mallinckrodt
US Army

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot